MINVASYS SAS
MINVASYS SAS provides solutions for the treatment of cardiovascular disorders.
MINVASYS SAS
Industry:
Health Care
Founded:
2003-01-01
Address:
Gennevilliers, Ile-de-France, France
Country:
France
Status:
Active
Contact:
+33 1 47 90 70 30
Similar Organizations
Cardionovum
Cardionovum provides cardiovascular medical solutions for the treatment of coronary and peripheral artery disease.
CPAP Store Ltd
CPAP Store Ltd provides sleep apnea devices for the treatment of respiratory disorders.
Magdalena Clinic
Magdalena Clinic provides patients with comprehensive cardiovascular care.
More informations about "MINVASYS SAS"
MINVASYS SAS - Crunchbase Company Profile & Funding
MINVASYS SAS provides solutions for the treatment of cardiovascular disorders. MINVASYS SAS was acquired by Stentys on Jan 30, 2018. Where is MINVASYS SAS's headquarters? …See details»
Minvasys Company Profile 2024: Valuation, Investors, …
Information on acquisition, funding, investors, and executives for Minvasys. Use the PitchBook Platform to explore the full profile.See details»
Minvasys SAS - Company Profile and News - Bloomberg …
Company profile page for Minvasys SAS including stock price, company news, executives, board members, and contact informationSee details»
Stentys acquires MINVASYS SAS - 2018-01-30 - Crunchbase
MINVASYS SAS MINVASYS SAS provides solutions for the treatment of cardiovascular disorders. Acquiring Organization: Stentys Stentys is a Coronary artery bifurcation stenosis …See details»
Minvasys - Overview, News & Similar companies
View Minvasys (www.minvasys.com) location in Ile-de-France, France , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Minvasys - Products, Competitors, Financials, Employees, …
Minvasys is an independent specialist in coronary devices marketed worldwide. Use the CB Insights Platform to explore Minvasys's full profile.See details»
MINVASYS SAS - Tech Stack, Apps, Patents
MINVASYS SAS provides solutions for the treatment of cardiovascular disorders.See details»
STENTYS Announces Plans to Acquire MINVASYS, …
Founded in the Paris area in 2003, MINVASYS is an independent company that specializes in Minimally INvasive VAscular SYStems. It capitalizes on the substantial expertise of its staff and...See details»
Minvasys SAS:Company Profile & Technical …
Minvasys is a company that provides Cardiovascular Disorder, Health care, Drug-eluting stent and more. Minvasys is headquartered in France Ile-de-France. Minvasys was founded in 2003.See details»
Isabelle Martin: Positions, Relations and Network
Chairman at Minvasys SAS, Discover Isabelle Martin's known position history, network and 0 relationships. Find out about his known public assets.See details»
Minvasys: Tailoring the Stent to Fit the Lesion in …
Feb 1, 2006 · Minvasys: Tailoring the Stent to Fit the Lesion in Bifurcations 01 Mar 2008 Bifurcated lesions remain one of the most challenging unmet clinical needs facing …See details»
Isabelle Martin: Latest news and mentions - MarketScreener
Find the latest stock market news mentioning Isabelle Martin, Chairman at Minvasys SAS on MarketScreenerSee details»
Minvasys SAS:Company Profile & Technical …
Minvasys is a company that provides Cardiovascular Disorder, Health care, Drug-eluting stent and more. Minvasys is headquartered in France Ile-de-France. Minvasys was founded in 2003. …See details»
Patents Assigned to Minvasys, SA - Justia Patents Search
Nov 30, 2017 · Patents Assigned to Minvasys, SA Catheter system for angioplasty and stenting with embolic protection Publication number: 20100174352See details»
Bioabsorbable Stents (BAS) Pipeline Report Including …
Apr 19, 2023 · All the vital news, analysis, and commentary curated by our industry experts. Published: April 19, 2023 Report Code: GDME1519EPD-ST. Bioabsorbable stents are also …See details»
MINVASYS SAS - Crunchbase
MINVASYS SAS provides solutions for the treatment of cardiovascular disorders.See details»
Procedural and early clinical outcomes of patients with de …
Aims: To demonstrate the acute and early outcomes of the novel Nile PAX dedicated polymer-free paclitaxel-coated stents (Minvasys SAS, Gennevilliers, France) in the treatment of de novo …See details»
Stentys - Funding, Financials, Valuation & Investors
Stentys has acquired 2 organizations. Their most recent acquisition was MINVASYS SAS on Jan 30, 2018. Which types of acquisition does this organization make most frequently? Stentys is a …See details»
Minvasys’s Nile Pax DES System Approved in Europe for …
Dec 16, 2009 · Minvasys has conducted international registries on the Nile CroCo bare-metal stent platform that has been CE Mark approved since 2005 and shortly will be closing a 100 …See details»
Paclitexel versus sirolimus-coated balloon in the treatment …
Methods: Between November 5, 2009, and October 14, 2020, in our center 212 patients with first DES-ISR were treated with PCB (Restore ®; Cardionovum GmbH, Bonn, Germany), whereas …See details»